Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012. ,
Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study, Diabetes Care, vol.37, issue.1, pp.17-23, 2014. ,
DOI : 10.2337/dc13-2251
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus ,
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, N ,
Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of followup in the DCCT/EDIC. Diabetes. 2015 Feb Blood pressure control for diabetic retinopathy Long-term follow-up after tight control of blood pressure in type 2 diabetes Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, CD006127. 12, pp.968-83, 1960. ,
Intravitreal Triamcinolone for Refractory Diabetic Macular EdemaTwo-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial, Ophthalmology, vol.113, issue.9, pp.1533-1541, 2006. ,
DOI : 10.1016/j.ophtha.2006.02.065
Intravitreal Triamcinolone Prior to Laser Treatment of Diabetic Macular Edema, Ophthalmology, vol.118, issue.5, pp.866-72, 2011. ,
DOI : 10.1016/j.ophtha.2010.09.029
Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Diabetic Retinopathy Clinical Research Network (DRCR.net), pp.158-601447, 1960. ,
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina Phila Pa, pp.915-938, 2011. ,
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema, Ophthalmology, vol.121, issue.10, pp.1904-1918, 2014. ,
DOI : 10.1016/j.ophtha.2014.04.024
Repeated intravitreal dexamethasone implant (ozurdex) for diabetic macular edema. Retina Phila Pa, pp.1216-1238, 2015. ,
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology Diabetic Retinopathy Clinical Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema, Ophthalmology, vol.119117119, issue.10611, pp.2125-2157, 2010. ,
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema, Ophthalmology, vol.118, issue.4, pp.609-623, 2011. ,
DOI : 10.1016/j.ophtha.2010.12.033
The RESTORE Study, Ophthalmology, vol.118, issue.4, pp.615-640, 2011. ,
DOI : 10.1016/j.ophtha.2011.01.031
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes ,
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2, Ophthalmology, vol.116117, issue.116, pp.2175-81, 2009. ,
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.110, issue.6, pp.735-778, 2009. ,
DOI : 10.1007/s00417-008-1034-x
A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema, Archives of Ophthalmology, vol.130, issue.8, pp.972-981, 1960. ,
DOI : 10.1001/archophthalmol.2012.393
Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina Phila Pa, pp.1053-60, 2008. ,
Anti???Vascular Endothelial Growth Factor Pharmacotherapy for Diabetic Macular Edema, Ophthalmology, vol.119, issue.10, pp.2179-88, 2012. ,
DOI : 10.1016/j.ophtha.2012.07.058
A controlled study of vitrectomy for diabetic macular edema Diabetic Retinopathy Clinical Research Network Writing Committee Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction, Am J Ophthalmol Ophthalmology. Frank RN. Diabetic retinopathy. N Engl J Med, vol.134117350, issue.261, pp.214-223, 2002. ,
Changes in Visual Impairment Prevalence by Period of Diagnosis of DiabetesThe Wisconsin Epidemiologic Study of Diabetic Retinopathy, Ophthalmology, vol.116, issue.10, pp.1937-1979, 2009. ,
DOI : 10.1016/j.ophtha.2009.03.012
Global data on visual impairment in the year 2002. Bull World Health Organ, 2004. ,
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema, Ophthalmology, 1984. ,
Liverpool Diabetic Eye Study Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema, Lancet. Ophthalmology, vol.361102, issue.93531, pp.195-200, 1995. ,
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema, Ophthalmology, 1989. ,
A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care, pp.2856-63, 2005. ,
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care, 2003. ,
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States, JAMA Ophthalmology, vol.132, issue.11, pp.1334-1374, 2014. ,
DOI : 10.1001/jamaophthalmol.2014.2854
The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus, Ophthalmology, vol.117, issue.1, pp.63-70, 2010. ,
DOI : 10.1016/j.ophtha.2009.06.051
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes, Ophthalmology, vol.116, issue.3, pp.497-503, 2009. ,
DOI : 10.1016/j.ophtha.2008.10.016
The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care, pp.1731-1738, 2003. ,
Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe, Ophthalmology, vol.104, issue.2, pp.252-60, 1997. ,
DOI : 10.1016/S0161-6420(97)30327-3
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes, UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet Lond Engl, pp.20-24, 1993. ,
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, vol.353, issue.25, pp.2643-53, 2005. ,
Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med, 1989. ,
UK Prospective Diabetes Study Group Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69 The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate, The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, pp.1631-401261, 1960. ,
Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database):e0132492. 63 Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy, PloS One. JAMA Ophthalmol, vol.10, issue.7, 2015. ,
The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology High prevalence of sleep disordered breathing in patients with diabetic macular edema. Retina Phila Pa Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study, Respir Int Rev Thorac Dis, vol.1153284, issue.394, pp.533-542, 2008. ,
The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema HAS. Haute Autorité de Santé-Rapport sur la tomographie du segment postérieur par scanographie à cohérence optique Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography, Br J Ophthalmol. Ophthalmology, vol.91111, issue.704, pp.1593-1598, 2004. ,
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME, CD008081. 72. Nunes S, 2011. ,
Repeatability of Spectralis OCT Measurements of Macular Thickness and Volume in Diabetic Macular Edema, Investigative Opthalmology & Visual Science, vol.53, issue.12, pp.7754-7763, 2012. ,
DOI : 10.1167/iovs.12-10895
Reproducibility of Retinal Thickness Measurements in Healthy Subjects Using Spectralis Optical Coherence Tomography, American Journal of Ophthalmology, vol.147, issue.3, pp.467-72, 2009. ,
DOI : 10.1016/j.ajo.2008.09.005
RETINAL THICKNESS AND VOLUME MEASUREMENTS IN DIABETIC MACULAR EDEMA, Retina, vol.31, issue.1, pp.48-55, 2011. ,
DOI : 10.1097/IAE.0b013e3181e095a4
Evaluation of Time Domain and Spectral Domain Optical Coherence Tomography in the Measurement of Diabetic Macular Edema, Investigative Opthalmology & Visual Science, vol.49, issue.10, pp.4290-4296, 2008. ,
DOI : 10.1167/iovs.08-2113
Optical Coherence Tomography May Be Used to Predict Visual Acuity in Patients with Macular Edema, Investigative Opthalmology & Visual Science, vol.52, issue.5, pp.2741-2749, 2011. ,
DOI : 10.1167/iovs.09-4493
Optical Coherence Tomographic Pattern May Predict Visual Outcome after Intravitreal Triamcinolone for Diabetic Macular Edema, Ophthalmology, vol.114, issue.5, pp.890-894, 2007. ,
DOI : 10.1016/j.ophtha.2006.11.026
Optical Coherence Tomography Findings in Persistent Diabetic Macular Edema: The Vitreomacular Interface, American Journal of Ophthalmology, vol.144, issue.5 ,
DOI : 10.1016/j.ajo.2007.07.012
Association of Pathomorphology, Photoreceptor Status, and Retinal Thickness With Visual Acuity in Diabetic Retinopathy, American Journal of Ophthalmology, vol.151, issue.2, pp.310-317, 2011. ,
DOI : 10.1016/j.ajo.2010.08.022
Association of Disorganization of Retinal Inner Layers With Vision After Resolution of Center-Involved Diabetic Macular Edema, Threedimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema, pp.820-825, 2015. ,
CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY, Retina, vol.34, issue.6, 2014. ,
DOI : 10.1097/IAE.0000000000000053
Baseline Choroidal Thickness as a Predictor for Response to Anti???Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema, American Journal of Ophthalmology, vol.159, issue.1, pp.85-91 ,
DOI : 10.1016/j.ajo.2014.09.033
Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema. Ophthalmology, 2007. ,
Relationship between fluorescein pooling and optical coherence tomographic reflectivity of cystoid spaces in diabetic macular edema Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group, Ophthalmology. Ophthalmology, vol.11998, issue.875, pp.1047-55, 1991. ,
Recommandations de l'ALFEDIAM pour le dépistage et la surveillance de la rétinopathie diabétique Focal photocoagulation treatment of diabetic macular edema Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group Diabetic macular edema: what is focal and what is diffuse?, Diabetes Metab. Arch Ophthalmol Chic Ill Ophthalmology. Browning DJ, Altaweel MM, Bressler NM Am J Ophthalmol, vol.11398146, issue.655, pp.203-212, 1960. ,
Diabetic macular edema: an OCT-based classification. Semin Ophthalmol Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial, Diabetes Control and Complications Trial Research Group. Ophthalmology, vol.19102, issue.124, pp.13-20, 1995. ,
Relationship of Prospective GHb to Glycated Serum Proteins in Incident Diabetic Retinopathy Implications of the glycation gap for mechanism of risk prediction. Diabetes Care, 2008. ,
UK Prospective Diabetes Study (IKPDS) Group. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52), Diabet Med J Br Diabet Assoc, vol.18, issue.3, pp.178-84, 2001. ,
UKPDS): 10 years later] Rev Médicale Liège Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group, Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial, pp.624-633, 1960. ,
Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, vol.358, issue.24, pp.2545-59, 2008. ,
Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, vol.362, issue.17, pp.1575-85, 2010. ,
Effects of combination lipid therapy in type 2 diabetes mellitus, N Engl J Med, 2010. ,
Effects of medical therapies on retinopathy progression in type 2 diabetes, N Engl J Med Jul, vol.15363, issue.3, pp.233-277, 2010. ,
Effect of systemic medications on onset and progression of diabetic retinopathy, Nature Reviews Endocrinology, vol.92, issue.9, 2010. ,
DOI : 10.1038/nrendo.2010.122
Treatment effects of captopril on nonproliferative diabetic retinopathy, Chin Med J (Engl, vol.125, issue.2, pp.287-92 ,
Fenofibrate ??? A Potential Systemic Treatment for Diabetic Retinopathy?, American Journal of Ophthalmology, vol.154, issue.1, pp.6-12 ,
DOI : 10.1016/j.ajo.2012.03.013
Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study, Ophthalmic Epidemiology, vol.366, issue.9500, pp.307-324, 2014. ,
DOI : 10.1016/j.ophtha.2010.02.031
Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group, Arch Ophthalmol Chic Ill, vol.103, issue.12, pp.1796-806, 1960. ,
GREEN OR YELLOW LASER TREATMENT FOR DIABETIC MACULAR EDEMA, Retina, vol.33, issue.10, 2013. ,
DOI : 10.1097/IAE.0b013e318295f744
MICROPERIMETRY AND FUNDUS AUTOFLUORESCENCE IN DIABETIC MACULAR EDEMA, Retina, vol.30, issue.6, pp.908-924, 2010. ,
DOI : 10.1097/IAE.0b013e3181c96986
Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema, Expert Review of Medical Devices, vol.9, issue.2, pp.189-97 ,
DOI : 10.1586/erd.12.1
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser, Clin Ophthalmol Auckl NZ, vol.7, pp.121-129, 2013. ,
Clinical Evaluation and Treatment Accuracy in Diabetic Macular Edema Using Navigated Laser Photocoagulator NAVILAS, Ophthalmology, vol.118, issue.6, pp.1119-1143, 2011. ,
DOI : 10.1016/j.ophtha.2010.10.007
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina Phila Pa, pp.999-1005, 2006. ,
A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema, Ophthalmology, vol.121, issue.12, pp.2473-81, 2014. ,
DOI : 10.1016/j.ophtha.2014.07.002
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial, Ophthalmology, vol.120, issue.11, pp.2300-2309, 2013. ,
DOI : 10.1016/j.ophtha.2013.06.020
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema, American Journal of Ophthalmology, vol.142, issue.6, pp.961-970, 2006. ,
DOI : 10.1016/j.ajo.2006.06.068
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results, Ophthalmology, vol.119, issue.11, pp.2312-2320, 2012. ,
Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema, Ophthalmology, vol.120, issue.10, pp.2004-2016, 2013. ,
DOI : 10.1016/j.ophtha.2013.02.019
Efficacite et tole rance du traitement par ranibizumab administré selon un protocole treat-and-extend versus pro re nata pour une baisse d'acuité visuelle dûe à un oedème maculaire diabétique: étude RETAIN. Communication orale à la Société Française d'Ophtalmologie, Ophtalmologie, vol.2013 ,
A Prospective Randomized Trial of Intravitreal Bevacizumab Versus Ranibizumab for the Management of??Diabetic Macular Edema, American Journal of Ophthalmology, vol.156, issue.3, pp.502-512, 2013. ,
DOI : 10.1016/j.ajo.2013.04.026
One-year outcomes of the da Vinci Study of VEGF Trap-Eye ,
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema, New England Journal of Medicine, vol.372, issue.13, pp.1193-203, 2015. ,
DOI : 10.1056/NEJMoa1414264
Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina Phila Pa, 2004. ,
Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema, Ophthalmology, vol.116, issue.5, 2009. ,
DOI : 10.1016/j.ophtha.2009.02.002
Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection, Archives of Ophthalmology, vol.110, issue.2, 1960. ,
DOI : 10.1001/archopht.1992.01080140115038
Vitrectomy for diabetic macular edema: a systematic review and meta-analysis, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol.49, issue.2, 2014. ,
DOI : 10.1016/j.jcjo.2013.11.012
Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.246, issue.11, pp.71-79 ,
DOI : 10.1007/s00417-011-1777-7
Ocriplasmin for diabetic retinopathy, Expert Opinion on Biological Therapy, vol.35, issue.12, pp.1741-1748, 2013. ,
DOI : 10.1001/archopht.1993.01090020056023
Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade, Retina Phila Pa. 2015, vol.35, issue.5, pp.929-963 ,
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema, Ophthalmology, vol.118, issue.4, pp.626-661, 2011. ,
DOI : 10.1016/j.ophtha.2010.12.028
The Royal College of Ophthalmologists??? clinical guidelines for diabetic retinopathy: a summary, Eye, vol.27, issue.2, pp.285-292, 2013. ,
DOI : 10.1038/eye.2012.287
Hoskins Center for Quality Eye Care Diabetic Retinopathy PPP -2014 [Internet] Available from: http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy, 2014. ,
Enquête des pratiques de la DMLA en France. Communication orale SFO. Société Française d'ophtalmologie, 2014. ,
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration, British Journal of Ophthalmology, vol.120, issue.2, pp.220-226, 2015. ,
DOI : 10.1136/bjophthalmol-2014-305327
CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE, Retina, vol.33, issue.3, pp.474-81, 2013. ,
DOI : 10.1097/IAE.0b013e31827b6324
Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany], Ophthalmol Z Dtsch Ophthalmol Ges, vol.112, issue.3, pp.246-54, 2015. ,
Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol.46, issue.3, pp.227-258, 2011. ,
DOI : 10.1016/j.jcjo.2011.05.013
Real World Vision Ourcomes in DME Treated with Anti-VEGF Injections-An analysis of EMR Data From a Large Health System-Paper session-ARVO 2014, ARVO Annual meeting Abstrats, 2014. ,
Real-world ourcomes of ranibizumab treatment for diabetic macular edema-Paper session-ARVO 2015, ARVO 2015 Annual Meeting Abstracts, 2015. ,
Résultats au long cours du traitement de l'oedème maculaire diabétique par Ranibizumab en pratique clinique-Communication Orale, pdf 152. ONDPS, Observatoire National de la Démographie des Professions de Santé ,
Recommandations FFM-Oedème maculaire diabétique: diagnostic et bilan préthérapeutique [Internet]. Fédérarion France Macula Available from ,
The Wisconsin Epidemiologic Study of Diabetic Retinopathy, Archives of Ophthalmology, vol.102, issue.4, pp.520-526, 1960. ,
DOI : 10.1001/archopht.1984.01040030398010
EVALUATION OF VISUAL ACUITY, MACULAR STATUS, AND SUBFOVEAL CHOROIDAL THICKNESS CHANGES AFTER CATARACT SURGERY IN EYES WITH DIABETIC RETINOPATHY, Retina, vol.35, issue.2, 2015. ,
DOI : 10.1097/IAE.0000000000000298
Analysis of Macular Edema after Cataract Surgery in Patients with Diabetes Using Optical Coherence Tomography, Ophthalmology, vol.114, issue.5, 2007. ,
DOI : 10.1016/j.ophtha.2006.08.053
Development and Progression of Diabetic Retinopathy 12 Months after Phacoemulsification Cataract Surgery, Ophthalmology, vol.116, issue.8, pp.1510-1514, 2009. ,
DOI : 10.1016/j.ophtha.2009.03.003
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets, Ophthalmology, vol.122, issue.7, p.2015 ,
DOI : 10.1016/j.ophtha.2015.03.024
Diabetic retinopathy and inflammation: novel therapeutic targets, Middle East Afr J Ophthalmol. 2012, vol.19, issue.1, pp.52-61 ,
Bonnes pratiques d'injection intra-vitréenne (IVT) [Internet], 2011. ,
Indication de l'antibioprophylaxie lors des injections intravitréennes-SFO [Internet] Available from, 2015. ,
FRenCh Retina specialists net) Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome, MEDECIN Am J Ophthalmol. 2015, vol.160, issue.1, pp.17-25 ,
IVT d'anti-VEGF considérez-vous qu'un patient est résistant (et donc non répondeur) à la molédule? 26, Quels critères peuvent vous conduire à arrêter les IVT ou à changer de molécule ,